FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer
Clinical trial NCT01206530 · COMPLETED
Trial details
- NCT number
- NCT01206530
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2017-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.